Planta Med 2005; 71(7): 646-653
DOI: 10.1055/s-2005-871271
Original Paper
Natural Product Chemistry
© Georg Thieme Verlag KG Stuttgart · New York

Antihepatitis Activity (Anti-HBsAg and Anti-HBeAg) of C19 Homolignans and Six Novel C18 Dibenzocyclooctadiene Lignans from Kadsura japonica

Yao-Haur Kuo1 , Ming-Der Wu1 , 2 , Ray-Ling Huang1 , Li-Ming Yang Kuo1 , Ya-Wen Hsu1 , Chia-Ching Liaw1 , 3 , Chia-Cheng Hung1 , Ya-Ching Shen3 , Chi-Wi Ong2
  • 1National Research Institute of Chinese Medicine, Shih-Pai, Taipei, Taiwan, R.O.C.
  • 2Institute of Chemistry, National Sun Yat-Sen University, Kaohsiung, Taiwan, R.O.C
  • 3Institiute of Marine Resources, National Sun Yat-Sen University, Kaohsiung, Taiwan, R.O.C.
Weitere Informationen

Publikationsverlauf

Received: August 23, 2004

Accepted: January 6, 2005

Publikationsdatum:
18. Juli 2005 (online)

Preview

Abstract

Bioassay-directed fractionation of the EtOAc extract of Kadsura japonica has led to the isolation of six new C18 dibenzocyclooctadiene lignans, schizanrins I, J, K, L, M, N, along with four known C19 homolignans, taiwanschirins A, B, C, and heteroclitin F. The elucidations of the new structures were based on spectral analysis. Bioassay evaluation against human type B hepatitis revealed that taiwanschirins A and B showed strong activity for anti-HBsAg and a medium effect for anti-HBeAg at 25 μg/mL (12.9 and 11.9 μM for taiwanschirins A and B, respectively).

References

Prof. Yao-Haur Kuo

National Research Institute of Chinese Medicine

Shih-Pai

Taipei 112

Taiwan

Republic of China

Telefon: 886-2-28201999 ext. 7061

Fax: +886-2-28236150

eMail: kuoyh@nricm.edu.tw